Advancement in the development of gene/protein-based vaccines against African swine fever virus

IF 4.8 Q1 MICROBIOLOGY

Current Research in Microbial Sciences Pub Date : 2024-01-01 DOI:10.1016/j.crmicr.2024.100232

Ning Wang , Pan Huang , Jun Zhang , Minqi Lin , Xiaoru Lai , Jianwen Chen , Chungen Pan

{"title":"Advancement in the development of gene/protein-based vaccines against African swine fever virus","authors":"Ning Wang , Pan Huang , Jun Zhang , Minqi Lin , Xiaoru Lai , Jianwen Chen , Chungen Pan","doi":"10.1016/j.crmicr.2024.100232","DOIUrl":null,"url":null,"abstract":"<div><p>African swine fever (ASF) is a highly contagious acute hemorrhagic viral disease, with the mortality rate of up to 100 % in domestic pigs. In recent years, ASF outbreaks have caused huge economic losses in numerous countries and regions, especially in Asia. Therefore, there is a pressing need to develop safe and effective vaccines against infection of the causative pathogen, African swine fever virus (ASFV). ASFV contains a large genome composed of double-stranded DNA with a size of 170–194 kb, which encodes nearly 200 viral proteins. Understanding the function of these complex genes/proteins and their roles in the generation of protective immunity will help in the development of ASFV vaccines. In this article, the gene/protein-based vaccine candidate are summarized, and the structural proteins which have been previously reported to protect animals from the virus challenge were emphatically described.</p></div>","PeriodicalId":34305,"journal":{"name":"Current Research in Microbial Sciences","volume":"6 ","pages":"Article 100232"},"PeriodicalIF":4.8000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666517424000142/pdfft?md5=577c2c1d51722e2a55abf9ee21b17e8e&pid=1-s2.0-S2666517424000142-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research in Microbial Sciences","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666517424000142","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

African swine fever (ASF) is a highly contagious acute hemorrhagic viral disease, with the mortality rate of up to 100 % in domestic pigs. In recent years, ASF outbreaks have caused huge economic losses in numerous countries and regions, especially in Asia. Therefore, there is a pressing need to develop safe and effective vaccines against infection of the causative pathogen, African swine fever virus (ASFV). ASFV contains a large genome composed of double-stranded DNA with a size of 170–194 kb, which encodes nearly 200 viral proteins. Understanding the function of these complex genes/proteins and their roles in the generation of protective immunity will help in the development of ASFV vaccines. In this article, the gene/protein-based vaccine candidate are summarized, and the structural proteins which have been previously reported to protect animals from the virus challenge were emphatically described.

Abstract Image

查看原文本刊更多论文

开发基于基因/蛋白质的非洲猪瘟病毒疫苗的进展情况

非洲猪瘟（ASF）是一种传染性极强的急性出血性病毒病，家猪死亡率高达 100%。近年来，非洲猪瘟疫情在许多国家和地区造成了巨大的经济损失，尤其是在亚洲。因此，迫切需要开发安全有效的疫苗来预防致病病原体非洲猪瘟病毒（ASFV）的感染。非洲猪瘟病毒包含一个由双链 DNA 组成的大型基因组，大小为 170-194 kb，其中编码近 200 种病毒蛋白。了解这些复杂基因/蛋白的功能及其在产生保护性免疫中的作用将有助于开发 ASFV 疫苗。本文对基于基因/蛋白的候选疫苗进行了总结，并重点描述了之前报道的能保护动物免受病毒挑战的结构蛋白。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊